Derma Sciences Regions Map

Select your location from over 190 countries where Derma Sciences operates.

About Derma Sciences Inc.

Tissue Regeneration in Wound Care Across the Spectrum

Derma Sciences is a Tissue Regeneration Company at the forefront of research and innovation for the management of acute and chronic wounds, and burns. The products we bring to the market are in the best tradition of evidence-based medicine, helping clinicians around the world improve clinical outcomes.

With you in mind, our portfolio has grown to provide clinicians with solutions to assist with tissue regeneration - from the start of a wound through to wound closure. From MEDIHONEY®, to XTRASORB®, to BIOGUARD®, ALGICELL® Ag, TCC-EZ® and now, AMNIOEXCEL® and AMNIOMATRIX®, our intelligent, evidence-based products help to advance healing for patients suffering from complex chronic or acute wounds such as diabetic foot ulcers, venous leg ulcers, pressure ulcers and burns.

Company Highlights

LIMB PRESERVATION: Awaken the wound for proper healing with MEDIHONEY - 17 November 2015

To preserve limbs from amputation, use of multiple advanced therapies at different phases of wound healing is often necessary. If the wound is not properly prepared for successful healing, it is difficult to get your patient off that stairway to amputation. MEDIHONEY®, through its multiple mechanisms of action, helps to prepare an optimal wound healing environment that can encourage the wound to successfully accept other advanced therapies such as AMNIOEXCEL®, an Amniotic Allograft Membrane.

TCC-EZ and MedE-Kast now have the APMA Seal of Approval - 29 October 2015

Derma Sciences is pleased to announce that our market leading TCC-EZ® and MedE-Kast® Total Contact Casting Systems now have the APMA Seal of Approval (American Podiatric Medical Association). The APMA is the leading resource for foot and ankle health information and the organization represents the majority of the estimated 15,000 podiatrist practicing in the United States.

Do Chronic Venous Leg Ulcers (VLUs) challenge you and your patients? Watch the latest BIOGUARD Power Webinar! - 18 August 2015

Chronic venous leg ulcers (VLUs) are considered to be the most common leg ulcers in the ambulatory elderly population in developed countries. These ulcers have a major impact on a person’s Quality of Life (QoL) which can include pain, wound exudate and odor, to name a few.

Reimbursement Alert On MEDIHONEY Products! - 13 August 2015

Voice your concerns about proposed coverage and reimbursement Medicare Part B changes to MEDIHONEY® products.
The DME Medicare Administrative Contractors [DME MAC] are intending to make surgical dressing policy changes not based on clinical practice, notably proposing to eliminate coverage of surgical dressings with multiple components including MEDIHONEY® dressings. This coverage change is based on the relative weight of honey within the dressing, not based on the clinical merits of the dressing. We believe this makes no sense and will have dramatic negative impact on how you are able to manage your patients' wounds.

Harnessing MEDIHONEY to Heal Lower Extremity Diabetic and Venous Leg Ulcers - 29 July 2015

In this educational program, the scientific benefits behind the naturally low pH and high osmotic effect of MEDIHONEY® will be discussed and various cases will be presented. This is a 30-minute educational program on harnessing the unique characteristics of MEDIHONEY® Dressings to promote the healing DFUs and VLUs.